Société Cellectar Biosciences Inc Nasdaq
Actions
US15117F3029
Produits pharmaceutiques
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
James V. Caruso
CEO | Chief Executive Officer | 65 | 15/06/15 |
Chad J. Kolean
DFI | Director of Finance/CFO | 59 | 28/05/14 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/23 |
Jarrod Longcor
COO | Chief Operating Officer | 51 | 15/07/16 |
Shane Lea
PRN | Corporate Officer/Principal | - | 21/11/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 07/04/17 |
Douglas Swirsky
CHM | Chairman | 54 | 07/04/17 |
John Neis
BRD | Director/Board Member | 68 | 01/02/08 |
James V. Caruso
CEO | Chief Executive Officer | 65 | 15/06/15 |
Stefan Loren
BRD | Director/Board Member | 60 | 15/06/15 |
Director/Board Member | 55 | 24/06/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 320 | 0 | 0 | 88,18 % |
Action B | 0 | 111 | 0 | 0 | |
Action C | 0 | 1 237 | 0 | 0 | |
Action D | 1 | 32 260 510 | 28 446 406 ( 88,18 %) | 0 |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83 % | 653 Md | |
+27,00 % | 556 Md | |
-6,76 % | 354 Md | |
+20,34 % | 331 Md | |
+3,00 % | 296 Md | |
+13,09 % | 233 Md | |
+5,46 % | 201 Md | |
-9,61 % | 193 Md | |
-6,26 % | 144 Md |